(Allogenic) CAR NK Cells: From Bench to Bedside

Part III: Seminar Series: From target validation to clinical application

We at Miltenyi see ourselves not only as tool providers but also have a strong expertise in the development of cell and gene therapy products. With our seminar series we would like to educate and share our experiences in developing cell and gene therapy approaches – starting from target validation via the proof of principle in small scale through to clinical scale.

For registration, information and questions please refer to Caren Clark carenb@miltenyi.com